Clinuvel Pharmaceuticals Limited,engages in the developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders.
Business Segments
The company operates within a singular operating segment, fo…
Analysis
Quality compounder
Clinuvel Pharmaceuticals Limited is a quality compounder: a well-run business trading at a price that reflects what it is worth. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is attractive. You pay 14.4× its owner earnings: the cash an owner could take out each year, which is in the historically attractive zone.
The trajectory is moderate and the balance sheet is sturdy. The company scores 12/20 on our value-creation score: creating some value.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Mar 202691
96
2026
All-time high
96
Jun 2026
All-time low
91
Mar 2026
Average rank
94
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
42
—
—
—
Price/Earnings
73
—
—
—
Price/Book
69
—
—
—
Dividend Yield
73
—
—
—
Value (overall)
85
—
—
—
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.